Tissue and recovery
ARA-290 / Cibinetide
EPO-derived peptide evaluated in small human studies of small-fibre neuropathy.
Search names: Ara-290, Cibinetide
Evidence
Human · small pilot trial
Describes the linked sources, not an overall score for product quality or effectiveness.Half-life
No value has been added to this entry.
Half-life, duration of effect and shelf life are different measures. Catalogue values may differ between variants and administration routes. Curves continue to use their stated statistics reference.
Adverse effects and limitations
Adverse effects are not fully mapped in this entry. Consult the sources for the specific compound and use.
Sources and further reading
Vital · user-supplied screen recordings, 1 Nov 2026
Study / medicine dataARA-290 · randomized pilot study↗Find researchPubMed · ARA-290 / Cibinetide↗Research information, not a personal dosing plan. Last reviewed: 2026-11-01.